$HRTX

HERON THERAPEUTICS, INC. /DE/

No enriched coverage for $HRTX in the last 7 days.

No SEC Form 4 filings for $HRTX in the last 30 days.

Med

Heron sets May 11 webcast for Q1 results and business updates

Heron Therapeutics (Nasdaq: HRTX) announced it will report its first-quarter 2026 financial results and discuss business highlights on Monday, May 11, 2026, at 8:30 a.m. ET. The event will include a conference call and live webcast accessible through registration on the company's investor relations website, where an archive will also be available for 60 days. Investors are advised to register and dial in 15 minutes early to avoid delays.

Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026

Heron Therapeutics announced it will report its first quarter 2026 financial results on Monday, May 11, 2026, through a conference call and live webcast. The event, scheduled for 8:30 a.m. ET, will also cover recent business highlights. Interested parties can access dial-in details via a registration link or the Investor Relations section of the company's website.